Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents

被引:379
作者
Jordan, VC [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
关键词
D O I
10.1021/jm020450x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:1081 / 1111
页数:31
相关论文
共 421 条
  • [1] Proteasome-mediated proteolysis of estrogen receptor: A novel component in autologous down-regulation
    Alarid, ET
    Bakopoulos, N
    Solodin, N
    [J]. MOLECULAR ENDOCRINOLOGY, 1999, 13 (09) : 1522 - 1534
  • [2] EVIDENCE FOR THE METABOLIC-ACTIVATION OF NON-STEROIDAL ANTIOESTROGENS - A STUDY OF STRUCTURE-ACTIVITY-RELATIONSHIPS
    ALLEN, KE
    CLARK, ER
    JORDAN, VC
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1980, 71 (01) : 83 - 91
  • [3] Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
  • [4] [Anonymous], 1998, LANCET, V351, P1451
  • [5] EXPRESSION OF RAS P21, P53 AND C-ERBB-2 IN ADVANCED BREAST-CANCER AND RESPONSE TO FIRST LINE HORMONAL-THERAPY
    ARCHER, SG
    ELIOPOULOS, A
    SPANDIDOS, D
    BARNES, D
    ELLIS, IO
    BLAMEY, RW
    NICHOLSON, RI
    ROBERTSON, JFR
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (05) : 1259 - 1266
  • [6] Arteaga CL, 2001, J CLIN ONCOL, V19, p32S
  • [7] A realistic clinical perspective of tamoxifen and endometrial carcinogenesis
    Assikis, VJ
    Neven, P
    Jordan, VC
    Vergote, I
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (09) : 1464 - 1476
  • [8] EFFECTS OF TAMOXIFEN TREATMENT ON PLASMA-LIPIDS AND LIPOPROTEIN LIPID-COMPOSITION
    BAGDADE, JD
    WOLTER, J
    SUBBAIAH, PV
    RYAN, W
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) : 1132 - 1135
  • [9] Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial
    Barrett-Connor, E
    Grady, D
    Sashegyi, A
    Anderson, PW
    Cox, DA
    Hoszowski, K
    Rautaharju, P
    Harper, KD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07): : 847 - 857
  • [10] Lack of evidence for tamoxifen- and toremifene-DNA adducts in lymphocytes of treated patients
    Bartsch, H
    Phillips, DH
    Nair, J
    Hewer, A
    Meyberg-Solomeyer, G
    Grischke, EM
    [J]. CARCINOGENESIS, 2000, 21 (04) : 845 - 847